بوابة منظمة الأغذية والزراعة للتعاون بين بلدان الجنوب

Animal Influenza Laboratory (AIL) of Harbin Veterinary Research Institute (HVRI)

Address
No. 427 Maduan St. 150001, Harbin, Heilongjiang Province
Country
China
Phone number(s)
+86-189-4606-6220
Areas of expertise
البحوث والإرشاد في مجال الزراعة, الصحة الحيوانية والخدمات البيطرية
Mandate, main activities of the institution and competencies

Mandate

The arbitrative diagnosis of highly pathogenic avian influenza; development of diagnostic and surveillance and analysis of virus variation; vaccine development, evaluation and update; as well as the exploration of the molecular basis for the virulence and host range of the avian influenza viruses. The research achievements of this division should provide technical consultation and products support to national policy regarding the control and prevention of animal influenza.

 

Competencies

Harbin Veterinary Research Institute (HVRI),subordinated to the Chinese Academy of Agricultural Sciences (CAAS),is located in Harbin, a beautiful and famous cultural city in northeast China. It was founded in June, 1948 as the first veterinary medicine research institute in China.

The primary objective of the Harbin Veterinary Research Institute (HVRI), CAAS is to protect the health of husbandry animals, to ensure the security of public health, and to promote scientific and technological developments for the prevention and control of animal infectious diseases.

 

Focal points

Contact: Zhang Jing

Email: [email protected]

Tel: +86 189-4606-6220

Fax: +86 451-51997166 

Address: No. 427 Maduan St. 150001, Harbin, P.R. China

List of experts

TITLE & FULL NAME: Dr. CHEN Hualan, Professor AREAS OF EXPERTISE: Virology, Vaccinology NO. YEARS OF EXPERIENCE: 20 years

CHEN Hualan is a virologist whose research focus is the study of influenza and the development of vaccines against this virus. She has established several platforms for avian influenza vaccine development, and over 140 billion doses of the vaccines developed by her have been used to control H5N1 influenza in poultry in China and other countries. She also performs extensive basic research to understand the evolution and the genetic basis of the virulence and host range of avian influenza viruses, and has published over 100 papers in international peer-reviewed journals, including Science. She was selected as one of “the 10 people that mattered in 2013” by the prominent interdisciplinary scientific journal Nature.

TITLE & FULL NAME: Dr. LI Chengjun, Professor
AREAS OF EXPERTISE:
Virology
NO. YEARS OF EXPERIENCE
: 15 years

LI Chengjun is a virologist whose research focus is to understand the mechanisms of pathogenesis, variation, replication regulation and anti-viral immunity of avian influenza viruses. He is also interested in the epidemiology of avian influenza viruses and the development of avian influenza vaccines. He has published over 30 papers in international peer-reviewed journals, such as PNAS, Trends in Biotechnology and Journal of Virology.

TITLE & FULL NAME: Dr. QIAO Chuanling, Professor
AREAS OF EXPERTISE: Virology
NO. YEARS OF EXPERIENCE: 15 years

QIAO Chuanling is a virologist whose research focus is the vaccine development for animal influenza viruses and the epidemiology of swine influenza viruses. She developed a fowlpox virus vectored H5N1 avian influenza vaccine, which has been licensed for the control of H5N1 influenza in poultry of China. She is also engaged in surveillance and development of diagnostic reagents for swine influenza. She has over 80 publications in international and national peer-reviewed journals.

TITLE & FULL NAME: TIAN Guobin, Professor
AREAS OF EXPERTISE: Vaccinology
NO. YEARS OF EXPERIENCE: 20 years

TIAN Guobin is an expert in avian influenza prevention and control techniques. He developed nearly 20 varieties of avian influenza vaccines, including the serial avian influenza vaccines of H5 subtype that have been used in China and other countries to control the H5 avian influenza. He is also an expert in international technical assistance on the prevention and control of avian influenza in Asian and African countries, such as Viet Nam, North Korea, and Egypt. He has won 14 Science & technology awards in China, and has published nearly 40 papers in international peer-reviewed journals.

TITLE & FULL NAME: Dr. DENG Guohua, Professor
AREAS OF EXPERTISE: Virology, Epidemiology
NO. YEARS OF EXPERIENCE: 20 years

DENG Guohua is a virologist whose research focus is the surveillance, epidemiology, and genetic, antigenic and pathogenic characterization of avian influenza viruses. His research played important role in the identification and update of avian influenza vaccine seed viruses used in China. He has also performed some basic research to understand the evolution and molecular basis of pathogenesis and transmission of avian influenza viruses. He is the author of over 20 papers published in international peer-reviewed journals.

TITLE & FULL NAME: Dr. LI Yanbing, Professor
AREAS OF EXPERTISE: Virology, Epidemiology
NO. YEARS OF EXPERIENCE: 20 years

LI Yanbing is a virologist whose research focus is the study of influenza virus and its epidemiology. She has diagnosed and confirmed most of the outbreak cases of H5 subtype highly pathogenic avian influenza in poultry and wild birds in China, fulfilled the surveillance on live poultry markets and nature reserves around the country, performed extensive basic research to understand the evolution and the genetic basis of the virulence and host range of avian influenza viruses, and selected representative isolates to be used as vaccine donor candidates. She has published over 40 papers in international peer-reviewed journals.

TITLE & FULL NAME: Dr. JIANG Yongping, Professor
AREAS OF EXPERTISE:
Virology, Vaccinology
NO. YEARS OF EXPERIENCE
: 16 years

JIANG Yongping is a virologist whose research interest is the development of avian influenza vaccines and the understanding of molecular mechanisms of influenza virus infection and pathogenesis. She developed a DNA vaccine platform for avian influenza, and had completed the large-scale clinical experiment. The application licence of her DNA vaccine is close to be issued in China. She also contributed to the establishment of a duck enteritis virus-based live vaccine platform. She has published over 35 papers in international peer-reviewed journals.